Similarly, CDK4/6 inhibition has been shown to inhibit the proliferation of several colon cancer cell lines in vitro [38], induce regression of a human colon cancer xenograft (Colo-205) [22], and induce regression of multiple myeloma xenografts which specifically overexpress CDK6 [39]. Here, CDK6 is linked to malignant colon neoplasm.